[Value of hemosorption and essential phospholipids in the complex treatment of patients with ischemic heart disease].

Abstract

Eighty-three patients were treated with hemosorption and essential phospholipids for coronary heart disease (CHD) and followed up for 3-5 years. The new approach to the treatment of CHD involves simultaneous removal of cholesterol-rich atherogenic lipoproteins by hemosorption and administration of essential phospholipids to increase cholesterol withdrawal… (More)

Topics

  • Presentations referencing similar topics